Dr. Daniel Peters discussed targeted therapies and regimens that patients with acute myeloid leukemia, or AML, should be aware of.
Dr. Daniel Peters
Advertisement
Articles by Dr. Daniel Peters
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
Every FDA Oncology Approval From November 2025
2
FDA Approves Breyanzi in Relapsed/Refractory Marginal Zone Lymphoma
3
What Patients Should Know About EGFR Mutated Lung Cancer Treatment
4
11 Years Living With Stage 4 Cancer Inspires Gratitude and Reflection
5
